HomeBusiness NewsNew Paper Offers Practical Roadmap for Using Real-World Data in FDA Drug...

New Paper Offers Practical Roadmap for Using Real-World Data in FDA Drug Approvals and Label Expansi…

September 25, 2026

- Advertisement -

BLUEBELL, Pa.–(BUSINESS WIRE)–Slipstream co-authors a new CPT paper with practical guidance for using real-world data in FDA drug approvals and label expansions.

Click here to view the original article.

Tags
Business Wire

- Advertisment -

New GCDLA committee invites practitioners to meet the judiciary – Proctor

WA news LIVE: Former Eagles star pays tribute to partner who died following childbirth; Four people charged over shooting in Perth’s south

New Paper Offers Practical Roadmap for Using Real-World Data in FDA Drug Approvals and Label Expansi…

Recently Viewed

KidsCan highlights hidden cost of child poverty in ‘Reflections’ via Droga5

Law firms and AML/CTF compliance: The real test may be whether you can prove it – Proctor

The Block 2027 Sunbury homes plans revealed

Bentley Torcal Electric SUV: First Review of the V8-Inspired EV

FEATURED

Great White shark bites fishing boat off Sunshine Coast

Volcanic cloud from Whakaari White Island halts flights

Great Koala Count: Aussies urged to track sightings of iconic marsupials

POPULAR POSTS

Is Taylor Swift’s “Patient Zero” About Joe Jonas? The Theory

Kohli announces next World Cup will be his last; County Championship title race, third day – live | Sport

Alan Cumming Breaks Down His Gonzo ‘Traitors’ Wardrobe

POPULAR CATEGORY

FOLLOW US

New Paper Offers Practical Roadmap for Using Real-World Data in FDA Drug Approvals and Label Expansi…

RELATED ARTICLES

Recently Viewed

FEATURED

POPULAR POSTS

POPULAR CATEGORY

FOLLOW US